Navigation Links
Chief Medical Officer Summit for Biotechs Goes West
Date:6/17/2013

New York, NY (PRWEB) June 17, 2013

With the huge success of CMO East, we are thrilled to announce the launch of the Chief Medical Officer Summit for Emerging Life Science Companies on the West Coast! CMO West will take place in San Francisco on November 4-5, 2013 at the Marines Memorial Club & Hotel.

For the first time, West Coast Chief Medical Officers at biotechs have their own conference, thanks to the idea from Dr. Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director of The Conference Forum, the event organizer said, “We are grateful to Dr. Stoner’s idea for the conference and her insights into the unique challenges CMOs face every day at small to mid-size biotechs.”

The Chief Medical Officer Summit West is dedicated to accomplishing two goals:

1. To provide a forum to address the unique needs of Emerging Life Science Chief Medical Officers in de-risking drug development, selecting and managing CROs, leveraging capital to manage all R&D functions with limited resources, working more successfully with investors and strategizing for appropriate exits in the current environment.

2. To create a network of Life Science CMOs to form a community that can shares ideas, solutions and support.

Boston attendee Dominic J.F. Tong, MD said of the program, "It is a pleasure to have attended a historic meeting [of] the outstanding inaugural Chief Medical Officer Summit."

CMO West speaker Santosh Vetticaden, PhD, MD, CMO, SVP, Mast Therapeutics, Inc., said, "I found the East Coast meeting extremely useful since it was designed exclusively to addressing CMO interests. The opportunity to network with my peers at this event was invaluable since, barring this meeting, interactions I have with my peers tend to be at scientific meetings where the focus is the scientific meeting and not the CMO peer interactions."

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

The Speaking Faculty: Full Biographies Available Here

Srinivas Akkaraju, MD, PhD, General Partner, Sofinnova Ventures
Lee Allen, MD, PhD, CMO, Spectrum Pharmaceuticals
Zoran Antonijevic, Senior Director, Strategic Consulting and Adaptive Implementation, Cytel Inc.
Mohammad Azab, MD, MBA, CMO, Astex Pharmaceuticals
Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH
Jill Carroll, Senior Associate, SR One
Farah Champsi, MBA, Managing Director, Alta Partners
Adam Craig, MD, PhD MBA, EVP, Development & CMO, Sunesis Pharmaceuticals, Inc.
Howard Dittrich, MD, CMO, Sorbent Therapeutics
Sheila Gujrathi, MD, CMO, Receptos, Inc.
Barry Hafkin, MD, CMO, Affinium Pharmaceuticals
Laurie Halloran, BSN, MS, President & CEO, Halloran Consulting Group, Inc.
Julie Hambleton, MD, SVP & CMO, Five Prime Therapeutics
M. Scott Harris, MD, CMO / Principal / Clinical Professor of Medicine, Avaxia Biologics, Inc. / Middleburg Consultants / Georgetown University School of Medicine
Rekha Hemrajani, MBA, Vice President, Head of Licensing & M&A, Onyx Pharmaceuticals
Jan Johansson, MD, PhD, SVP Medical Affairs, Resverlogix
Jeff Jonker, Former Chief Business Officer, Satori Pharmaceuticals
Lori Kunkel, MD, CMO, PCYC
Jeffery Loutit, MBChB, CMO, Rempex Pharmaceuticals
Jonathan MacQuitty, PhD, MBA, Partner, Abingworth
Tyler Martin, MD, Former President, CMO & Director, Dynavax Technologies
Nestor Molfino, MD, CMO, KaloBios
Pamela Palmer, MD, PhD, CMO, AcelRx Pharmaceuticals, Inc.
Hemai Parthasarathy, PhD, Scientific Director, Breakout Labs, The Thiel Foundation
Carol Sands, Managing General Partner / Founder, The Halo Funds / The Angels’ Forum
Tracy Saxton, PhD, Associate, SV Life Sciences
Oscar Segurado, MD, PhD, CMO, Crescendo Bioscience
Jeffrey Sherman, MD, FACP, CMO & EVP, Development, Manufacturing and Regulatory Affairs, Horizon Pharma
Stephen Shrewsbury, MD, MBChB, MRCGP, FCCP, FACAAI, FFPM, FAAAAI, SVP, Clinical Development & CMO, Aquinox Pharmaceuticals
Michael Sweeney, MD, CMO & VP of R&D, Depomed
Frank Torti, MD, Principal, NEA
Santosh Vetticaden, MD, PhD, CMO, SVP, Mast Therapeutics, Inc.
Samuel Wu, MD, PhD, Managing Director, MedImmune Ventures

Read the full story at http://www.prweb.com/releases/2013/6/prweb10826992.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
5. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
6. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
7. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
8. Codexis Names Wes Bolsen VP and Chief Marketing Officer
9. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
10. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
11. GenVec President and Chief Executive Officer Announces Retirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... February 04, 2016 , ... Morf Media Inc ... an interactive FDA compliance training course, Writing Effective SOPs ... accredited interactive course on Morf Playbook—now conveniently available on smartphones and PCs--provides step ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... and triple quad LC-MS, host live demos and poster sessions, and present on ... exhibition. The conference takes place March 6 to 10 at the Georgia World ...
(Date:2/4/2016)... JUNCTION, N.J. , Feb. 4, 2016 /PRNewswire/ ... care immunotherapy leader commercializing its flagship CytoSorb® blood ... cardiac surgery patients around the world, announced that ... will present at the Source Capital Group,s 2016 ... and update on the company.  ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016 ContraVir ... focused on the development and commercialization of targeted antiviral ... CEO & Investor Conference 2016, to be held February ... Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... on February 10-11, 2016. James Sapirstein , ...
Breaking Biology Technology:
(Date:2/2/2016)... 2, 2016  BioMEMS devices deployed in ... on medical screening and diagnostic applications, such ... devices that facilitate and assure continuous monitoring ... are being bolstered through new opportunities offered ... acquisition coupled with wireless connectivity and low ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
Breaking Biology News(10 mins):